Coronasomnia: A Hidden Problem of the COVID era. Is Melatonin a Potential Solution?

Abstract

Globally, changes in work cultures have impacted on all life, and individuals have reported increased insomnia “Coronasomnia” as a result of COVID-19. Correct nutrition, in relation to micronutrient concentration, may have beneficial effects in controlling our biological sleep clocks. Specifically, melatonin supplementaions are being recommended for the COVID generation. However, there have been J Food Sci Nutr Res 2022; 5 (1): 325-340 DOI: 10.26502/jfsnr.2642-11000084 Journal of Food Science and Nutrition Research Vol. 5 No. 1 March 2022. [ISSN 2642-1100] 326 mixed reports regarding melatonin supplementation using high dosages for certain population groups, and there may be disadvantages in using melatonin as an exogenous supplement (oral tablet or injectable drug) in the long term. As a result, melatonin may not be suitable for all post COVID generations without further clinical trials. However, melatonin as a dietary supplement could have significant health benefits without causing any adverse effects. Therefore, the main aim of this opinion article is to highlight the challenges of “Coronasomnia” related to COVID 19, which has been overlooked. In addition, we highlight the research need for clinical trials on melatonin supplementation for inclusion in the diets of the COVID generation. Supplementation regimes using naturally occurring melatonin obtained from dietary sources will regulate central biological cycle naturally. Consequently, future research is needed to investigate whether melatonin containing foods are clinically beneficial to the COVID generation by increasing the bioavailability of melatonin using dietary supplementation.